Our results confirmed the previous findings of Shien et al. [35], showing that the JAK family of tyrosine-kinases, especially JAK1, is a critical type of kinase that mediates the activation of STAT3 through IL-6 cytokines in NSCLC cells. This evidence concerns the gene IL6 and non-small cell lung carcinoma.